About IN8Bio

About company

Incysus Therapeutics is a operator of a biotechnology company intended to develop immune-based therapies for the treatment of cancer. The company's services focus on utilizing genetically modified gamma-delta T cells across a Drug Resistance Immunotherapy (DRI) platform that addresses the challenges faced while targeting cold, low mutation cancers, enabling the targeting of malignant cells and potentially more effective treatments for patients with difficult-to-treat solid tumor cancers.